GlassScriptPhysician profile
Jordan Lindsie Cone
NPI 1023634680
$284.09
in general payments reported to CMS, 2019-2025
10 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $101 · 2023: $18.90 · 2024: $52.46 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $165 · Education: $18.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $164.67 |
| Education | $18.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $90.24 | 2022-2024 | Paragard T 380a |
| Organon LLC | $39.26 | 2022-2025 | Nexplanon |
| Vertex Pharmaceuticals Incorporated | $36.19 | 2024-2025 | |
| Novo Nordisk INC | $19.87 | 2025 | |
| Intuitive Surgical, INC. | $18.90 | 2023 | Da Vinci Surgical System |
| Lilly USA, LLC | $18.34 | 2025 | Zepbound |
| Mayne Pharma Commercial LLC | $16.78 | 2025 | |
| Astellas Pharma US INC | $16.36 | 2025 | Veozah |
| Pfizer INC. | $16.05 | 2024 | |
| Puma Biotechnology, INC. | $12.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Cone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.